Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic ...
Cystic-fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback